Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313245518> ?p ?o ?g. }
- W4313245518 endingPage "178" @default.
- W4313245518 startingPage "178" @default.
- W4313245518 abstract "It is commonly reported that maximizing surgical resection of contrast-enhancing regions in patients with glioblastoma improves overall survival. Efforts to achieve an improved rate of resection have included several tools: among those, the recent widespread of fluorophores. Sodium fluorescein is an unspecific, vascular dye which tends to accumulate in areas with an altered blood–brain barrier. In this retrospective analysis of patients prospectively enrolled in the FLUOCERTUM study, we aimed to assess the role of fluorescein-guided surgery on surgical radicality, survival, and morbidity. A retrospective review based on 93 consecutively and prospectively enrolled IDH wild-type glioblastoma patients (2016–2022) was performed; fluorescence characteristics, rate of resection, clinical outcome, and survival were analyzed. No side effect related to fluorescein occurred; all of the tumors presented a strong yellow-green enhancement and fluorescein was judged fundamental in distinguishing tumors from viable tissue in all cases. Gross total resection was achieved in 77 cases out of 93 patients (82.8%). After a mean follow-up time of 17.4 months (3–78 months), the median progression-free survival was 12 months, with a PFS-6 and PFS-12 of 94.2% and 50%, respectively, whereas median overall survival was estimated to be 16 months; survival at 6, 12, and 24 months was 91.8%, 72.3%, and 30.1%, respectively. Based on these results, we can assert that the fluorescein-guided technique is a safe and valuable method for patients harboring a newly diagnosed, untreated glioblastoma." @default.
- W4313245518 created "2023-01-06" @default.
- W4313245518 creator A5000375031 @default.
- W4313245518 creator A5005464185 @default.
- W4313245518 creator A5006006756 @default.
- W4313245518 creator A5012650954 @default.
- W4313245518 creator A5013104556 @default.
- W4313245518 creator A5014654912 @default.
- W4313245518 creator A5015098738 @default.
- W4313245518 creator A5016926131 @default.
- W4313245518 creator A5031666313 @default.
- W4313245518 creator A5033398992 @default.
- W4313245518 creator A5034471018 @default.
- W4313245518 creator A5039965560 @default.
- W4313245518 creator A5045972173 @default.
- W4313245518 creator A5048278348 @default.
- W4313245518 creator A5056677028 @default.
- W4313245518 creator A5057646591 @default.
- W4313245518 creator A5085331836 @default.
- W4313245518 creator A5086832667 @default.
- W4313245518 date "2022-12-26" @default.
- W4313245518 modified "2023-09-28" @default.
- W4313245518 title "Towards an Established Intraoperative Oncological Favorable Tool: Results of Fluorescein-Guided Resection from a Monocentric, Prospective Series of 93 Primary Glioblastoma Patients" @default.
- W4313245518 cites W1523980033 @default.
- W4313245518 cites W155916090 @default.
- W4313245518 cites W1847836727 @default.
- W4313245518 cites W1990862650 @default.
- W4313245518 cites W1993873557 @default.
- W4313245518 cites W199396233 @default.
- W4313245518 cites W2005858732 @default.
- W4313245518 cites W2007744844 @default.
- W4313245518 cites W2023297519 @default.
- W4313245518 cites W2027226583 @default.
- W4313245518 cites W2033801160 @default.
- W4313245518 cites W2060341351 @default.
- W4313245518 cites W2062053619 @default.
- W4313245518 cites W2073873308 @default.
- W4313245518 cites W2073993866 @default.
- W4313245518 cites W2077884169 @default.
- W4313245518 cites W2096287682 @default.
- W4313245518 cites W2114150959 @default.
- W4313245518 cites W2120100866 @default.
- W4313245518 cites W2125372543 @default.
- W4313245518 cites W2127383724 @default.
- W4313245518 cites W2131981377 @default.
- W4313245518 cites W2135404870 @default.
- W4313245518 cites W2135575642 @default.
- W4313245518 cites W2143970185 @default.
- W4313245518 cites W2148977460 @default.
- W4313245518 cites W2151478922 @default.
- W4313245518 cites W2154898479 @default.
- W4313245518 cites W2162496354 @default.
- W4313245518 cites W2238211532 @default.
- W4313245518 cites W2300017805 @default.
- W4313245518 cites W2346612107 @default.
- W4313245518 cites W2366536035 @default.
- W4313245518 cites W2386703324 @default.
- W4313245518 cites W2436534309 @default.
- W4313245518 cites W2494360996 @default.
- W4313245518 cites W2526011086 @default.
- W4313245518 cites W2527718370 @default.
- W4313245518 cites W2562647854 @default.
- W4313245518 cites W2610403529 @default.
- W4313245518 cites W2627028058 @default.
- W4313245518 cites W2755004866 @default.
- W4313245518 cites W2763896294 @default.
- W4313245518 cites W2811335517 @default.
- W4313245518 cites W2905223314 @default.
- W4313245518 cites W2908084647 @default.
- W4313245518 cites W2914479798 @default.
- W4313245518 cites W2914964665 @default.
- W4313245518 cites W2917608491 @default.
- W4313245518 cites W2943967236 @default.
- W4313245518 cites W2965526215 @default.
- W4313245518 cites W2991564861 @default.
- W4313245518 cites W2993820680 @default.
- W4313245518 cites W2994973210 @default.
- W4313245518 cites W3020099303 @default.
- W4313245518 cites W3045566992 @default.
- W4313245518 cites W3046036769 @default.
- W4313245518 cites W3117209604 @default.
- W4313245518 cites W3160129686 @default.
- W4313245518 cites W3162024487 @default.
- W4313245518 cites W3165707712 @default.
- W4313245518 cites W3174246647 @default.
- W4313245518 cites W3174334627 @default.
- W4313245518 cites W3177299774 @default.
- W4313245518 cites W3206402529 @default.
- W4313245518 cites W3206733738 @default.
- W4313245518 cites W4213037770 @default.
- W4313245518 cites W4220730899 @default.
- W4313245518 cites W4226406387 @default.
- W4313245518 cites W4234865248 @default.
- W4313245518 cites W4242821555 @default.
- W4313245518 cites W4290730662 @default.
- W4313245518 cites W4303613705 @default.
- W4313245518 cites W911182017 @default.
- W4313245518 doi "https://doi.org/10.3390/jcm12010178" @default.